AHCA Pulled, End of Life Models, Biosimilars, MACRA, ASCO Lifting COI Restrictions
In this week’s BioBlog we look at the American Health Care Act being pulled, new research in various end of life models, the use of biosimilars to lower the cost of drug therapy, MACRA implementation, and ASCO removing conflict of interest restrictions on researchers.
Since they didn’t have the votes to pass it, Republicans pull the AHCA bill before voting on it, .
This article looks at the results of studies done with three different end of life models in an effort to reduce costs and increase quality of life.
In the future biosimilars may pave the way for lower-cost drug therapy, making it more accessible for patients.
Starting January 2017 MACRA went into place, but 2017 is a transition year and practices can begin implementing at their own pace. Read the article for further details and tips to help.
Recently ASCO removed these restrictions, which only made up a small percentage of the journals and abstracts.